Clinical Observation of Liuwei Nengxiao Capsules in the Treatment of Obesity and Constipation in Young Patients
Haichao Wei
Abstract
Haichao Wei
Abstract
OBJECTIVE:To observe the clinical efficacy and safety of Liuwei nengxiao capsule in the treatment of obesity in young patients with constipation.METHODS:82 patients were randomly divided into 2 groups.Treatment group were treated with Liuwei nengxiao capsule (2 capsules,tid) for 4 weeks (n=42),and control group were treated with compound glutamine enteric-coated capsules (2 capsules,tid) for 4 weeks (n=40).All patients were given proper guidance to diet,bowel habits,psychological status,lifestyle,etc.And relevant indicators were determined before and after treatment.RESULTS:The total effective rates were 76.19% for treatment group and 27.50% for control group,there was significant difference in clinical efficacy between 2 groups (P0.01).Serum total cholesterol,low-density lipoprotein and triglyceride were significantly decreased and high-density lipoprotein was significantly increased in treatment group,there was significant difference between 2 groups (P0.01).The improvement of abdominal pain and bloating resulting from constipation in treatment group were superior to in control group,there was statistical significance (P0.01).There was no significant difference between 2 groups before and after treatment in respects of blood count,electrolytes,liver and kidney function (P0.05).CONCLUSION:Liuwei nengxiao capsules shows good effects on regulating blood lipid and bowel function in young obesity patients with constipation,and it has sound safety and tolerance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the clinical efficacy and safety of Liuwei nengxiao capsule in the treatment of obesity in young patients with constipation.METHODS:82 patients were randomly divided into 2 groups.Treatment group were treated with Liuwei nengxiao capsule (2 capsules,tid) for 4 weeks (n=42),and control group were treated with compound glutamine enteric-coated capsules (2 capsules,tid) for 4 weeks (n=40).All patients were given proper guidance to diet,bowel habits,psychological status,lifestyle,etc.And relevant indicators were determined before and after treatment.RESULTS:The total effective rates were 76.19% for treatment group and 27.50% for control group,there was significant difference in clinical efficacy between 2 groups (P0.01).Serum total cholesterol,low-density lipoprotein and triglyceride were significantly decreased and high-density lipoprotein was significantly increased in treatment group,there was significant difference between 2 groups (P0.01).The improvement of abdominal pain and bloating resulting from constipation in treatment group were superior to in control group,there was statistical significance (P0.01).There was no significant difference between 2 groups before and after treatment in respects of blood count,electrolytes,liver and kidney function (P0.05).CONCLUSION:Liuwei nengxiao capsules shows good effects on regulating blood lipid and bowel function in young obesity patients with constipation,and it has sound safety and tolerance.
Key concepts: Medicine, Bloating, Constipation, Gastroenterology, Internal medicine, Capsule, Triglyceride, Abdominal pain